Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
OncoAlert Colloquium Day 3: Breast cancer
Dr Lambertini, Dr Hamilton, Dr Rugo, Dr Tolaney, Dr Meattini, Ms Maues, Ms Karmo
OncoAlert Colloquium Day 3: Breast cancer ( Dr Lambertini, Dr Hamilton, Dr Rugo, Dr Tolaney, Dr Meattini, Ms Maues, Ms Karmo )
23 Dec 2020
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma
Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma ( Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen )
23 Dec 2020
OncoAlert Colloquium Day 5: Genitourinary tumours and social media
Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal
OncoAlert Colloquium Day 5: Genitourinary tumours and social media ( Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal )
23 Dec 2020
Highlights from the 2020 European Cancer Organisation (ECO) summit
Prof Matti Aapro - President, European Cancer Organisation (ECO), Switzerland
Highlights from the 2020 European Cancer Organisation (ECO) summit ( Prof Matti Aapro - President, European Cancer Organisation (ECO), Switzerland )
22 Dec 2020
The present and future agenda of SIOG
Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore
The present and future agenda of SIOG ( Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore )
22 Dec 2020
SIOG 2020: Prostate task force and geriatric oncology during COVID 19
Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore
SIOG 2020: Prostate task force and geriatric oncology during COVID 19 ( Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore )
22 Dec 2020
Results of venetoclax and azacitidine combination in chemotherapy ineligible unt...
Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )
22 Dec 2020
Long-term follow-up of low-intensity chemotherapy with combination therapy for r...
Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )
22 Dec 2020
Real-world evidence of the use of carfilzomib among multiple myeloma patients ac...
Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020
Real-world evidence of the use of carfilzomib to refractory to lenalidomide pati...
Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumu...
Prof Evangelos Terpos - University of Athens, Athens, Greece
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020
2020 updates in treating NTRK fusion cancer
Dr Alexander Drilon and Prof Marc Peeters
2020 updates in treating NTRK fusion cancer ( Dr Alexander Drilon and Prof Marc Peeters )
22 Dec 2020